SCHEMBL16619801

SCHEMBL16619801

Cc1noc(C)c1-c1cccc(NC=C2C(=O)OC(C)(C)OC2=O)c1

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
HSD17B10 Q99714 2/20 0.53
MAPK1 P28482 1/20 0.53
RAB9A P51151 1/20 0.52
BRD4 O60885 10/20 0.50
HDAC1 Q13547 1/20 0.47
BRD2 P25440 7/20 0.46
CREBBP Q92793 3/20 0.46
TSHR P16473 1/20 0.46
BRD3 Q15059 3/20 0.44
NR3C1 P04150 1/20 0.41
PGR P06401 1/20 0.41
NR3C2 P08235 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18249913 0.81 ALDH1A1 (0.52) ALDH1A1CYP1A2CYP3A4HSD17B10MAPK1
SCHEMBL18249950 0.79 ALDH1A1 (0.51) ALDH1A1CYP1A2CYP3A4HSD17B10MAPK1
SCHEMBL3862485 0.79 ALDH1A1 (0.74) ALDH1A1CYP1A2CYP3A4HSD17B10MAPK1
SCHEMBL12095439 0.74 BRD4 (0.55) CYP3A4BRD4HDAC1BRD2CREBBP
SCHEMBL16619434 0.73 ALDH1A1 (0.42) ALDH1A1CYP1A2CYP3A4HSD17B10MAPK1
SCHEMBL12095520 0.73 BRD4 (0.57) ALDH1A1CYP1A2CYP3A4RAB9ABRD4
SCHEMBL19850569 0.72 ALDH1A1 (1.00) ALDH1A1CYP1A2CYP3A4HSD17B10MAPK1
SCHEMBL2172236 0.72 ALDH1A1 (0.70) ALDH1A1CYP1A2CYP3A4HSD17B10MAPK1
SCHEMBL2369281 0.72 ALDH1A1 (0.69) ALDH1A1CYP1A2CYP3A4HSD17B10MAPK1
SCHEMBL5217248 0.71 BRD4 (0.58) ALDH1A1CYP1A2CYP3A4RAB9ABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015049629-A1 IMIDAZOQUINOLINE COMPOUNDS AS BROMODOMAIN INHIBITORS Piramal Enterprises Limited (IN) 2015-04-09 WO disclosed